Americans spent over $50 billion on weight loss drugs like Ozempic and Wegovy last year, impacting the economy. GLP-1 medicines are evolving with new delivery methods. The drugs aim to address various health conditions beyond weight loss, potentially reshaping the labor force.
Stashing boxes of injectables in their carry-on luggage. Buying counterfeit formulas online. Importing boxes from Europe. The race to score blockbuster weight-loss #drugs is pushing wealthy Indians to creative lengths. @satvicked https://t.co/WjcoxEjQZN via @business
How wealthy Indians are buying Ozempic, other weight-loss drugs from gray market https://t.co/dhL6fx2Ubn
Ozempic frenzy lures rich Indians to brave the grey market https://t.co/IS3chzvyYu
Blockbuster weight-loss drugs could soon become a lot cheaper — and reach more people — thanks to Chinese and Indian pharmaceutical companies https://t.co/p67cciqwtq
#Ozempic frenzy lures #rich #Indians to brave the #GrayMarket https://t.co/pso2uB4dsk
Race For Blockbuster Weight-Loss Drugs Pushes Indians To Gray Market https://t.co/WzkSay9Zfa
Stashing boxes of injectables in their carry-on luggage. Buying counterfeit formulas online. Importing boxes from Europe. The race to score blockbuster weight-loss drugs is pushing wealthy Indians to creative lengths. https://t.co/mWV2MpSSMf via @business
Stashing boxes of injectables in their carry-on luggage. Buying counterfeit formulas online. Importing boxes from Europe. The race to score blockbuster weight-loss drugs is pushing wealthy Indians to creative lengths. https://t.co/n6I2YVDYVt
Both Ozempic and Wegovy currently cost ~$1000 per month and must be taken FOREVER. There are 105 million obese American adults and another 75 million overweight Americans. So, we could either spend $2 trillion per year on weekly injections or maybe move around a little more...
My latest @NewsHour story is about how GLP-1s (think: Wegovy, Ozempic, Zepbound) are reshaping the economy. They're already affecting grocery sales, what healthcare people need, government budgets, and potentially at some point, the broader labor force. https://t.co/I8Q6Vfdmv7
“Spending to reduce obesity is an investment in a healthier workforce,” writes Steven Pearson in a guest essay. As well as helping people lose weight, drugs such as Wegovy and Zepbound also lower other health-related risks, the doctor explains https://t.co/kFGwaaFzRI
Beyond control of glucose, #T2D #weightloss #obesity #heartdisease #kidney disease; Will GLP-1 medicines improve other conditions beyond anecdotal reports? We will soon find out @ginakolata https://t.co/KWZ3xoR2Em #arthritis
GLP-1 medicines started with injectable GLP-1RAs, then moved to oral peptides, and now co-agonists. The future will usher in multiple new ways of delivering GLP-1 medicines, and activating GLP-1R signaling pathways, promising improved efficacy/convenience. https://t.co/idKlbbzJFB https://t.co/XEuidlCj3P
Last year, Americans spent over $50 billion on weight loss drugs like Ozempic and Wegovy. Their popularity, and their price, are having effects throughout the economy. https://t.co/5ejrE6TdPA
Excerpt from my latest story for @NewsHour about the economic impacts of GLP-1 drugs -- for consumer spending habits, the healthcare system, and the labor force. Full story available here: https://t.co/I8Q6VfdUkF https://t.co/wKZ2hOGYEx
Last year, Americans spent over 50 billion dollars on weight loss drugs like ozempic and wegovy. Their popularity, and their price, are having effects throughout the economy. @crampell reports. https://t.co/Sioni8OpL4